nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP1A1—Dacarbazine—pancreatic cancer	0.114	0.121	CbGbCtD
Chlorzoxazone—CYP2A6—Tamoxifen—pancreatic cancer	0.106	0.112	CbGbCtD
Chlorzoxazone—CYP1A1—Tamoxifen—pancreatic cancer	0.0909	0.0961	CbGbCtD
Chlorzoxazone—CYP2E1—Dacarbazine—pancreatic cancer	0.0882	0.0933	CbGbCtD
Chlorzoxazone—CYP2A6—Fluorouracil—pancreatic cancer	0.0784	0.0829	CbGbCtD
Chlorzoxazone—CYP1A1—Erlotinib—pancreatic cancer	0.0773	0.0817	CbGbCtD
Chlorzoxazone—CYP2E1—Tamoxifen—pancreatic cancer	0.0702	0.0742	CbGbCtD
Chlorzoxazone—CYP1A2—Dacarbazine—pancreatic cancer	0.051	0.054	CbGbCtD
Chlorzoxazone—CYP1A2—Tamoxifen—pancreatic cancer	0.0406	0.0429	CbGbCtD
Chlorzoxazone—CYP1A2—Erlotinib—pancreatic cancer	0.0345	0.0365	CbGbCtD
Chlorzoxazone—CYP2D6—Tamoxifen—pancreatic cancer	0.0334	0.0354	CbGbCtD
Chlorzoxazone—CYP1A2—Fluorouracil—pancreatic cancer	0.0299	0.0316	CbGbCtD
Chlorzoxazone—CYP2D6—Erlotinib—pancreatic cancer	0.0284	0.0301	CbGbCtD
Chlorzoxazone—CYP3A4—Tamoxifen—pancreatic cancer	0.0213	0.0225	CbGbCtD
Chlorzoxazone—CYP3A4—Erlotinib—pancreatic cancer	0.0181	0.0191	CbGbCtD
Chlorzoxazone—CYP3A4—Irinotecan—pancreatic cancer	0.0163	0.0173	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—pancreatic cancer	0.014	0.0148	CbGbCtD
Chlorzoxazone—CYP3A4—Docetaxel—pancreatic cancer	0.012	0.0127	CbGbCtD
Chlorzoxazone—CYP3A4—Sunitinib—pancreatic cancer	0.0119	0.0126	CbGbCtD
Chlorzoxazone—CYP3A4—Doxorubicin—pancreatic cancer	0.00892	0.00944	CbGbCtD
Chlorzoxazone—Urine color abnormal—Sunitinib—pancreatic cancer	0.00741	0.136	CcSEcCtD
Chlorzoxazone—Chromaturia—Sunitinib—pancreatic cancer	0.00489	0.0896	CcSEcCtD
Chlorzoxazone—Lightheadedness—Tamoxifen—pancreatic cancer	0.00182	0.0334	CcSEcCtD
Chlorzoxazone—Petechiae—Gemcitabine—pancreatic cancer	0.0017	0.0312	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Erlotinib—pancreatic cancer	0.00146	0.0268	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.00104	0.0191	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.000999	0.0183	CcSEcCtD
Chlorzoxazone—Lightheadedness—Docetaxel—pancreatic cancer	0.000889	0.0163	CcSEcCtD
Chlorzoxazone—Petechiae—Epirubicin—pancreatic cancer	0.000815	0.0149	CcSEcCtD
Chlorzoxazone—Angioedema—Tamoxifen—pancreatic cancer	0.000814	0.0149	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—pancreatic cancer	0.000754	0.0138	CcSEcCtD
Chlorzoxazone—Discomfort—Tamoxifen—pancreatic cancer	0.000749	0.0137	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000721	0.0132	CcSEcCtD
Chlorzoxazone—Angioedema—Sunitinib—pancreatic cancer	0.000697	0.0128	CcSEcCtD
Chlorzoxazone—Dyspepsia—Tamoxifen—pancreatic cancer	0.00064	0.0117	CcSEcCtD
Chlorzoxazone—Dyspepsia—Erlotinib—pancreatic cancer	0.000633	0.0116	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000628	0.0115	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000621	0.0114	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—pancreatic cancer	0.000606	0.0111	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000583	0.0107	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000568	0.0104	CcSEcCtD
Chlorzoxazone—Malaise—Irinotecan—pancreatic cancer	0.000567	0.0104	CcSEcCtD
Chlorzoxazone—Ecchymosis—Doxorubicin—pancreatic cancer	0.000561	0.0103	CcSEcCtD
Chlorzoxazone—Malaise—Gemcitabine—pancreatic cancer	0.000552	0.0101	CcSEcCtD
Chlorzoxazone—Dyspepsia—Sunitinib—pancreatic cancer	0.000548	0.0101	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000538	0.00986	CcSEcCtD
Chlorzoxazone—Discomfort—Irinotecan—pancreatic cancer	0.000529	0.0097	CcSEcCtD
Chlorzoxazone—Discomfort—Gemcitabine—pancreatic cancer	0.000515	0.00945	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000513	0.00941	CcSEcCtD
Chlorzoxazone—Discomfort—Fluorouracil—pancreatic cancer	0.000506	0.00929	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.0005	0.00916	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000491	0.00901	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000487	0.00893	CcSEcCtD
Chlorzoxazone—Dizziness—Tamoxifen—pancreatic cancer	0.000481	0.00882	CcSEcCtD
Chlorzoxazone—Dizziness—Erlotinib—pancreatic cancer	0.000476	0.00872	CcSEcCtD
Chlorzoxazone—Rash—Tamoxifen—pancreatic cancer	0.000458	0.00841	CcSEcCtD
Chlorzoxazone—Dermatitis—Tamoxifen—pancreatic cancer	0.000458	0.0084	CcSEcCtD
Chlorzoxazone—Somnolence—Irinotecan—pancreatic cancer	0.000456	0.00836	CcSEcCtD
Chlorzoxazone—Rash—Erlotinib—pancreatic cancer	0.000454	0.00832	CcSEcCtD
Chlorzoxazone—Dermatitis—Erlotinib—pancreatic cancer	0.000453	0.00831	CcSEcCtD
Chlorzoxazone—Dyspepsia—Irinotecan—pancreatic cancer	0.000451	0.00828	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.00045	0.00826	CcSEcCtD
Chlorzoxazone—Somnolence—Gemcitabine—pancreatic cancer	0.000444	0.00815	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000443	0.00812	CcSEcCtD
Chlorzoxazone—Somnolence—Fluorouracil—pancreatic cancer	0.000437	0.00801	CcSEcCtD
Chlorzoxazone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000432	0.00793	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000431	0.00791	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000424	0.00778	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000423	0.00775	CcSEcCtD
Chlorzoxazone—Dizziness—Sunitinib—pancreatic cancer	0.000412	0.00755	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000412	0.00755	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000405	0.00743	CcSEcCtD
Chlorzoxazone—Rash—Sunitinib—pancreatic cancer	0.000393	0.0072	CcSEcCtD
Chlorzoxazone—Dermatitis—Sunitinib—pancreatic cancer	0.000392	0.00719	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—pancreatic cancer	0.000375	0.00688	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000355	0.0065	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—pancreatic cancer	0.000347	0.00636	CcSEcCtD
Chlorzoxazone—Dizziness—Irinotecan—pancreatic cancer	0.000339	0.00622	CcSEcCtD
Chlorzoxazone—Dizziness—Fluorouracil—pancreatic cancer	0.000325	0.00596	CcSEcCtD
Chlorzoxazone—Rash—Irinotecan—pancreatic cancer	0.000323	0.00593	CcSEcCtD
Chlorzoxazone—Dermatitis—Irinotecan—pancreatic cancer	0.000323	0.00593	CcSEcCtD
Chlorzoxazone—Somnolence—Docetaxel—pancreatic cancer	0.000315	0.00578	CcSEcCtD
Chlorzoxazone—Rash—Gemcitabine—pancreatic cancer	0.000315	0.00578	CcSEcCtD
Chlorzoxazone—Dermatitis—Gemcitabine—pancreatic cancer	0.000315	0.00577	CcSEcCtD
Chlorzoxazone—Dyspepsia—Docetaxel—pancreatic cancer	0.000312	0.00572	CcSEcCtD
Chlorzoxazone—Rash—Fluorouracil—pancreatic cancer	0.00031	0.00568	CcSEcCtD
Chlorzoxazone—Dermatitis—Fluorouracil—pancreatic cancer	0.000309	0.00568	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000306	0.00561	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000292	0.00536	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000272	0.00499	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—pancreatic cancer	0.000264	0.00485	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000252	0.00461	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—pancreatic cancer	0.000246	0.00452	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—pancreatic cancer	0.000244	0.00448	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000239	0.00439	CcSEcCtD
Chlorzoxazone—Dizziness—Docetaxel—pancreatic cancer	0.000234	0.0043	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—pancreatic cancer	0.000228	0.00418	CcSEcCtD
Chlorzoxazone—Rash—Docetaxel—pancreatic cancer	0.000224	0.0041	CcSEcCtD
Chlorzoxazone—Dermatitis—Docetaxel—pancreatic cancer	0.000223	0.0041	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000221	0.00406	CcSEcCtD
Chlorzoxazone—Somnolence—Epirubicin—pancreatic cancer	0.000213	0.0039	CcSEcCtD
Chlorzoxazone—Dyspepsia—Epirubicin—pancreatic cancer	0.000211	0.00386	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000206	0.00379	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000197	0.00361	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—pancreatic cancer	0.000197	0.00361	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000195	0.00357	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000191	0.0035	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000182	0.00334	CcSEcCtD
Chlorzoxazone—Dizziness—Epirubicin—pancreatic cancer	0.000158	0.0029	CcSEcCtD
Chlorzoxazone—Rash—Epirubicin—pancreatic cancer	0.000151	0.00277	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—pancreatic cancer	0.000151	0.00276	CcSEcCtD
Chlorzoxazone—Dizziness—Doxorubicin—pancreatic cancer	0.000146	0.00268	CcSEcCtD
Chlorzoxazone—Rash—Doxorubicin—pancreatic cancer	0.00014	0.00256	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—pancreatic cancer	0.000139	0.00256	CcSEcCtD
